Exosomes-based particles as inhalable COVID-19 vaccines
Coronavirus disease 2019 (COVID-19), a severely spreading pandemic, has dramatically brought physiological and economical burdens to people. Although the injectable vaccines have some achievements for coronavirus defense, they still generate accompanied pain, untoward reaction and cannot take part i...
Main Authors: | Lu Fan, Li Wang, Xiaoju Wang, Hongbo Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-12-01
|
Series: | Biomedical Technology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949723X2300003X |
Similar Items
-
Mucosal immune probiotic vector vaccines: Development and prospects for application in COVID-19
by: Renyun Zha, et al.
Published: (2023-01-01) -
COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
by: Ranjan Ramasamy
Published: (2023-10-01) -
Evaluation of Anti-SARS-CoV-2 IgA Response in Tears of Vaccinated COVID-19 Subjects
by: Irene Soffritti, et al.
Published: (2023-01-01) -
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
by: Kuldeep Dhama, et al.
Published: (2022-11-01) -
Delivery Routes for COVID-19 Vaccines
by: Jang Hyun Park, et al.
Published: (2021-05-01)